FY2028 EPS Forecast for DENTSPLY SIRONA Lifted by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Research analysts at Leerink Partnrs lifted their FY2028 earnings per share estimates for shares of DENTSPLY SIRONA in a report issued on Monday, July 14th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will earn $2.61 per share for the year, up from their previous estimate of $2.59. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The company's quarterly revenue was down 7.8% on a year-over-year basis. During the same period last year, the firm earned $0.42 EPS.

A number of other brokerages have also issued reports on XRAY. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday. Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research report on Monday, May 12th. Finally, UBS Group reduced their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Trading Down 0.2%

Shares of XRAY stock traded down $0.03 during trading on Thursday, hitting $15.78. 2,597,757 shares of the stock traded hands, compared to its average volume of 2,914,382. The firm has a market capitalization of $3.14 billion, a P/E ratio of -3.48, a price-to-earnings-growth ratio of 1.13 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. The firm's fifty day moving average price is $16.08 and its 200-day moving average price is $16.32. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $27.95.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently made changes to their positions in XRAY. Treasurer of the State of North Carolina raised its stake in DENTSPLY SIRONA by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after acquiring an additional 560 shares during the period. Quarry LP raised its stake in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after acquiring an additional 780 shares during the period. Public Employees Retirement System of Ohio grew its holdings in DENTSPLY SIRONA by 1.4% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier's stock valued at $983,000 after buying an additional 861 shares in the last quarter. Federated Hermes Inc. grew its holdings in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after buying an additional 915 shares in the last quarter. Finally, Gabelli Funds LLC grew its holdings in DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock valued at $1,464,000 after buying an additional 1,000 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.06%. The ex-dividend date was Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.